{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:58:43Z","timestamp":1784750323898,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hunan Provincial Science Fund for Distinguished Young Scholars","award":["2021JJ10068"],"award-info":[{"award-number":["2021JJ10068"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFF1201400"],"award-info":[{"award-number":["2021YFF1201400"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22173118"],"award-info":[{"award-number":["22173118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changsha Science and Technology Bureau project","award":["kq2001034"],"award-info":[{"award-number":["kq2001034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug\u2013drug interaction (DDI) often causes serious adverse reactions and thus results in inestimable economic and social loss. Currently, comprehensive DDI evaluation has become a major challenge in pharmaceutical research due to the time-consuming and costly process of the experimental assessment and it is of high necessity to develop effective in silico methods to predict and evaluate DDIs accurately and efficiently. In this study, based on a large number of substrates and inhibitors related to five important CYP450 isozymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4), a series of high-performance predictive models for metabolic DDIs were constructed by two machine learning methods (random forest and XGBoost) and 4 different types of descriptors (MOE_2D, CATS, ECFP4 and MACCS). To reduce the uncertainty of individual models, the consensus method was applied to yield more reliable predictions. A series of evaluations illustrated that the consensus models were more reliable and robust for the DDI predictions of new drug combination. For the internal validation, the whole prediction accuracy and AUC value of the DDI models were around 0.8 and 0.9, respectively. When it was applied to the external datasets, the model accuracy was 0.793 and 0.795 for multi-level validation and external validation, respectively. Furthermore, we also compared our model with some recently published tools and then applied the final model to predict FDA-approved drugs and proposed 54,013 possible drug pairs with potential DDIs. In summary, we developed a powerful DDI predictive model from the perspective of the CYP450 enzyme family and it will help a lot in the future drug development and clinical pharmacy research.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13321-022-00602-x","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T15:03:18Z","timestamp":1650034998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes"],"prefix":"10.1186","volume":"14","author":[{"given":"Ning-Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Gui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Li","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Jun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-3785","authenticated-orcid":false,"given":"Dong-Sheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"issue":"2","key":"602_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1021\/acs.molpharmaceut.5b00762","volume":"13","author":"AV Zakharov","year":"2016","unstructured":"Zakharov AV, Varlamova EV, Lagunin AA, Dmitriev AV, Muratov EN, Fourches D, Kuz\u2019Min VE, Poroikov VV, Tropsha A, Nicklaus MC (2016) QSAR modeling and prediction of drug\u2013drug interactions. Mol Pharm 13(2):545\u2013556. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00762","journal-title":"Mol Pharm"},{"issue":"1","key":"602_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2146\/ajhp070046","volume":"66","author":"JE Murphy","year":"2009","unstructured":"Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH (2009) Development of computerized alerts with management strategies for 25 serious drug-drug interactions. Am J Health Syst Pharm 66(1):38","journal-title":"Am J Health Syst Pharm"},{"issue":"18","key":"602_CR3","doi-asserted-by":"publisher","first-page":"E4304","DOI":"10.1073\/pnas.1803294115","volume":"115","author":"JY Ryu","year":"2018","unstructured":"Ryu JY, Kim HU, Lee SY (2018) Deep learning improves prediction of drug-drug and drug-food interactions. Proc Natl Acad Sci USA 115(18):E4304\u2013E4311. https:\/\/doi.org\/10.1073\/pnas.1803294115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"602_CR4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug events in hospitalized patients: a meta-analysis of prospective studies. JAMA J Am Med Assoc 279(15):1200\u20131205","journal-title":"JAMA J Am Med Assoc"},{"issue":"10","key":"602_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2165\/00002018-200124100-00001","volume":"24","author":"J Kuhlmann","year":"2001","unstructured":"Kuhlmann J, M\u00fcck W (2001) Clinical-pharmacological strategies to assess drug interaction potential during drug development. Drug Saf 24(10):715\u2013725","journal-title":"Drug Saf"},{"issue":"6","key":"602_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","volume":"29","author":"SF Zhou","year":"2007","unstructured":"Zhou SF, Xue CC, Yu XQ, Li C, Wang G (2007) Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit 29(6):687\u2013710. https:\/\/doi.org\/10.1097\/FTD.0b013e31815c16f5","journal-title":"Ther Drug Monit"},{"issue":"1","key":"602_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1021\/tx700079z","volume":"21","author":"FP Guengerich","year":"2008","unstructured":"Guengerich FP (2008) Cytochrome p450 and chemical toxicology. CHEM Res Toxicol 21(1):70\u201383. https:\/\/doi.org\/10.1021\/tx700079z","journal-title":"CHEM Res Toxicol"},{"issue":"12","key":"602_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002323","volume":"7","author":"XM Zhao","year":"2011","unstructured":"Zhao XM, Iskar M, Zeller G, Kuhn M, van Noort V, Bork P (2011) Prediction of drug combinations by integrating molecular and pharmacological data. PLos Comput Biol 7(12):e1002323. https:\/\/doi.org\/10.1371\/journal.pcbi.1002323","journal-title":"PLos Comput Biol"},{"issue":"11","key":"602_CR9","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1021\/ci200367w","volume":"51","author":"M Takarabe","year":"2011","unstructured":"Takarabe M, Shigemizu D, Kotera M, Goto S, Kanehisa M (2011) Network-based analysis and characterization of adverse drug\u2013drug interactions. J Chem Inf Model 51(11):2977\u20132985. https:\/\/doi.org\/10.1021\/ci200367w","journal-title":"J Chem Inf Model"},{"issue":"3","key":"602_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002998","volume":"9","author":"J Huang","year":"2013","unstructured":"Huang J, Niu C, Green CD, Yang L, Mei H, Han JD (2013) Systematic prediction of pharmacodynamic drug-drug interactions through protein\u2013protein-interaction network. PLos Comput Biol 9(3):e1002998. https:\/\/doi.org\/10.1371\/journal.pcbi.1002998","journal-title":"PLos Comput Biol"},{"issue":"12","key":"602_CR11","doi-asserted-by":"publisher","first-page":"e1003374","DOI":"10.1371\/journal.pcbi.1003374","volume":"9","author":"R Guimer\u00e3","year":"2013","unstructured":"Guimer\u00e3 R, Sales-Pardo M (2013) A network inference method for large-scale unsupervised identification of novel drug\u2013drug interactions. PLoS Comput Biol 9(12):e1003374","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"602_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13321-017-0200-8","volume":"9","author":"T Takeda","year":"2017","unstructured":"Takeda T, Hao M, Cheng T, Bryant SH, Wang Y (2017) Predicting drug\u2013drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge. J Cheminformatics 9(1):16","journal-title":"J Cheminformatics"},{"issue":"2","key":"602_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002375","volume":"8","author":"P Khatri","year":"2012","unstructured":"Khatri P, Sirota M, Butte AJ (2012) Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol 8(2):e1002375. https:\/\/doi.org\/10.1371\/journal.pcbi.1002375","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"602_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/amiajnl-2012-000935","volume":"19","author":"S Vilar","year":"2012","unstructured":"Vilar S, Harpaz R, Uriarte E, Santana L, Rabadan R, Friedman C (2012) Drug\u2013drug interaction through molecular structure similarity analysis. J Am Med Inf Assoc Jamia 19(6):1066","journal-title":"J Am Med Inf Assoc Jamia"},{"issue":"3","key":"602_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058321","volume":"8","author":"S Vilar","year":"2013","unstructured":"Vilar S, Uriarte E, Santana L, Tatonetti NP, Friedman C (2013) Detection of drug\u2013drug interactions by modeling interaction profile fingerprints. PLoS ONE 8(3):e58321. https:\/\/doi.org\/10.1371\/journal.pone.0058321","journal-title":"PLoS ONE"},{"key":"602_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040538","author":"AV Dmitriev","year":"2021","unstructured":"Dmitriev AV, Rudik AV, Karasev DA, Pogodin PV, Lagunin AA, Filimonov DA, Poroikov VV (2021) In silico prediction of drug\u2013drug interactions mediated by cytochrome P450 isoforms. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13040538","journal-title":"Pharmaceutics"},{"key":"602_CR17","unstructured":"Percha B, Garten Y, Altman RB. (2012). Discovery and explanation of drug\u2013drug interactions via text mining. Pac Symp Biocomput, 410\u2013421"},{"issue":"18","key":"602_CR18","doi-asserted-by":"publisher","first-page":"i547","DOI":"10.1093\/bioinformatics\/btq382","volume":"26","author":"L Tari","year":"2010","unstructured":"Tari L, Anwar S, Liang S, Cai J, Baral C (2010) Discovering drug\u2013drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics 26(18):i547\u2013i553. https:\/\/doi.org\/10.1093\/bioinformatics\/btq382","journal-title":"Bioinformatics"},{"key":"602_CR19","doi-asserted-by":"publisher","first-page":"12339","DOI":"10.1038\/srep12339","volume":"5","author":"P Zhang","year":"2015","unstructured":"Zhang P, Wang F, Hu J, Sorrentino R (2015) Label propagation prediction of drug\u2013drug interactions based on clinical side effects. Sci Rep 5:12339. https:\/\/doi.org\/10.1038\/srep12339","journal-title":"Sci Rep"},{"issue":"Database issue","key":"602_CR20","doi-asserted-by":"publisher","first-page":"D237","DOI":"10.1093\/nar\/gkp970","volume":"38","author":"S Preissner","year":"2010","unstructured":"Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R (2010) SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res 38(Database issue):D237\u2013D243. https:\/\/doi.org\/10.1093\/nar\/gkp970","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"602_CR21","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(Database issue):D668\u2013D672. https:\/\/doi.org\/10.1093\/nar\/gkj067","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"602_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1081\/DMR-120001392","volume":"34","author":"S Rendic","year":"2002","unstructured":"Rendic S (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 34(1\u20132):83\u2013448. https:\/\/doi.org\/10.1081\/DMR-120001392","journal-title":"Drug Metab Rev"},{"issue":"2","key":"602_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/amiajnl-2013-001612","volume":"21","author":"SV Iyer","year":"2014","unstructured":"Iyer SV, Harpaz R, LePendu P, Bauer-Mehren A, Shah NH (2014) Mining clinical text for signals of adverse drug\u2013drug interactions. J Am Med Inform Assoc 21(2):353\u2013362. https:\/\/doi.org\/10.1136\/amiajnl-2013-001612","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"602_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40264-015-0352-2","volume":"39","author":"JM Banda","year":"2016","unstructured":"Banda JM, Callahan A, Winnenburg R, Strasberg HR, Cami A, Reis BY, Vilar S, Hripcsak G, Dumontier M, Shah NH (2016) Feasibility of prioritizing drug-drug-event associations found in electronic health records. Drug Saf 39(1):45\u201357. https:\/\/doi.org\/10.1007\/s40264-015-0352-2","journal-title":"Drug Saf"},{"issue":"4","key":"602_CR25","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1021\/ci0500536","volume":"45","author":"CWY And","year":"2005","unstructured":"And CWY, Chen YZ (2005) Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and substrates by using support vector machines. J Chem Inf Model 45(4):982\u2013992","journal-title":"J Chem Inf Model"},{"issue":"4","key":"602_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1021\/acs.jcim.5b00642","volume":"56","author":"NN Wang","year":"2016","unstructured":"Wang NN, Dong J, Deng YH, Zhu MF, Wen M, Yao ZJ, Lu AP, Wang JB, Cao DS (2016) ADME properties evaluation in drug discovery: prediction of Caco-2 cell permeability using a combination of NSGA-II and boosting. J Chem Inf Model 56(4):763\u2013773. https:\/\/doi.org\/10.1021\/acs.jcim.5b00642","journal-title":"J Chem Inf Model"},{"key":"602_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13321-015-0109-z","volume":"7","author":"J Dong","year":"2015","unstructured":"Dong J, Cao DS, Miao HY, Liu S, Deng BC, Yun YH, Wang NN, Lu AP, Zeng WB, Chen AF (2015) ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation. J Cheminform 7:60. https:\/\/doi.org\/10.1186\/s13321-015-0109-z","journal-title":"J Cheminform"},{"issue":"6","key":"602_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/ci034160g","volume":"43","author":"V Svetnik","year":"2003","unstructured":"Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP (2003) Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 43(6):1947\u20131958. https:\/\/doi.org\/10.1021\/ci034160g","journal-title":"J Chem Inf Comput Sci"},{"issue":"2","key":"602_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.chemolab.2010.06.008","volume":"103","author":"DS Cao","year":"2010","unstructured":"Cao DS, Xu QS, Liang YZ, Chen X, Li HD (2010) Automatic feature subset selection for decision tree-based ensemble methods in the prediction of bioactivity. Chemom Intell Lab Syst 103(2):129\u2013136","journal-title":"Chemom Intell Lab Syst"},{"issue":"13","key":"602_CR30","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1021\/acsomega.1c00100","volume":"6","author":"H Liang","year":"2021","unstructured":"Liang H, Jiang K, Yan TA, Chen GH (2021) XGBoost: an optimal machine learning model with just structural features to discover MOF Adsorbents of Xe\/Kr. ACS Omega 6(13):9066\u20139076. https:\/\/doi.org\/10.1021\/acsomega.1c00100","journal-title":"ACS Omega"},{"issue":"15","key":"602_CR31","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39(15):2887\u20132893. https:\/\/doi.org\/10.1021\/jm9602928","journal-title":"J Med Chem"},{"issue":"41","key":"602_CR32","first-page":"239","volume":"33","author":"YJ Xu","year":"2010","unstructured":"Xu YJ, Johnson M (2010) Using molecular equivalence numbers to visually explore structural features that distinguish chemical libraries. J Chem Inf Comput Sci 33(41):239","journal-title":"J Chem Inf Comput Sci"},{"issue":"Suppl 19","key":"602_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12859-019-3214-6","volume":"20","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Peng H, Zhang X, Zhao Z, Gao X, Li J (2019) DDI-PULearn: a positive-unlabeled learning method for large-scale prediction of drug\u2013drug interactions. BMC Bioinform 20(Suppl 19):661. https:\/\/doi.org\/10.1186\/s12859-019-3214-6","journal-title":"BMC Bioinform"},{"issue":"10","key":"602_CR34","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1021\/acs.molpharmaceut.8b00110","volume":"15","author":"X Li","year":"2018","unstructured":"Li X, Xu Y, Lai L, Pei J (2018) Prediction of human cytochrome P450 inhibition using a multitask deep autoencoder neural network. Mol Pharm 15(10):4336\u20134345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00110","journal-title":"Mol Pharm"},{"issue":"9","key":"602_CR35","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1124\/dmd.120.000320","volume":"49","author":"E Gonzalez","year":"2021","unstructured":"Gonzalez E, Jain S, Shah P, Torimoto-Katori N, Zakharov A, Nguyen E, Sakamuru S, Huang R, Xia M, Obach RS, Hop C, Simeonov A, Xu X (2021) Development of robust quantitative structure-activity relationship models for CYP2C9, CYP2D6, and CYP3A4 catalysis and inhibition. Drug Metab Dispos 49(9):822\u2013832. https:\/\/doi.org\/10.1124\/dmd.120.000320","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"602_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1034\/j.1600-6143.2003.30202.x","volume":"3","author":"PV Kadambi","year":"2015","unstructured":"Kadambi PV, Josephson MA, James W, Lawrence C, Jerome KR, Meehan SM, Limaye AP (2015) Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 3(2):186\u2013191","journal-title":"Am J Transplant"},{"issue":"5","key":"602_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00003495-198223050-00001","volume":"23","author":"AA Carmine","year":"1982","unstructured":"Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS (1982) Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections. Drugs 23(5):329\u2013353","journal-title":"Drugs"},{"issue":"2","key":"602_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.2910460220","volume":"46","author":"S Binet","year":"2010","unstructured":"Binet S, Chaineau E, Fellous A, Lataste H, Krikorian A, Couzinier JP, Meininger V (2010) Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules. Int J Cancer 46(2):262\u2013266","journal-title":"Int J Cancer"},{"issue":"45","key":"602_CR39","doi-asserted-by":"publisher","first-page":"72807","DOI":"10.18632\/oncotarget.12020","volume":"7","author":"JT Burgess","year":"2016","unstructured":"Burgess JT, Bolderson E, Saunus JM, Zhang SD, Reid LE, Mcnicol AM, Lakhani SR, Cuff K, Richard K, Richard DJ (2016) SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer. Oncotarget 7(45):72807\u201372818","journal-title":"Oncotarget"},{"issue":"6","key":"602_CR40","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.ajog.2005.05.012","volume":"193","author":"A Sivojelezova","year":"2005","unstructured":"Sivojelezova A, Shuhaiber S, Sarkissian L, Einarson A, Koren G (2005) Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 193(6):2004\u20132009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"602_CR41","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1097\/00005344-198806124-00016","volume":"4","author":"A Zanchetti","year":"1988","unstructured":"Zanchetti A (1988) Nitrendipine and ACE inhibitors. J Cardiovasc Pharm 4(1):S80","journal-title":"J Cardiovasc Pharm"},{"issue":"11","key":"602_CR42","first-page":"1860","volume":"88","author":"WL Peterson","year":"1993","unstructured":"Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, Stratton CW, Drnec J, Prokocimer P, Siepman N (1993) Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 88(11):1860\u20131864","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-022-00602-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T15:07:41Z","timestamp":1650121661000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-022-00602-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1186\/s13321-022-00602-x","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"24 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}